Daniel Drocourt

908 total citations
17 papers, 694 citations indexed

About

Daniel Drocourt is a scholar working on Molecular Biology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Daniel Drocourt has authored 17 papers receiving a total of 694 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Immunology and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Daniel Drocourt's work include Monoclonal and Polyclonal Antibodies Research (4 papers), Glycosylation and Glycoproteins Research (3 papers) and HIV Research and Treatment (3 papers). Daniel Drocourt is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (4 papers), Glycosylation and Glycoproteins Research (3 papers) and HIV Research and Treatment (3 papers). Daniel Drocourt collaborates with scholars based in France, United Kingdom and Spain. Daniel Drocourt's co-authors include Gérard Tiraby, Éric Pérouzel, Jean-Paul Reynes, Thierry Calmels, Michel Baron, Gordon D. Brown, Stéphane Paul, Alain Vercellone, Jacques Prandi and Jérôme Nigou and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and The Journal of Immunology.

In The Last Decade

Daniel Drocourt

17 papers receiving 684 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Drocourt France 13 293 237 125 124 106 17 694
Sarah Murdoch United Kingdom 8 274 0.9× 262 1.1× 69 0.6× 111 0.9× 78 0.7× 8 901
Djenet Bousbaine United States 11 272 0.9× 148 0.6× 76 0.6× 114 0.9× 94 0.9× 15 589
Lenka Sadílková Czechia 12 320 1.1× 187 0.8× 54 0.4× 123 1.0× 64 0.6× 19 857
Elham Mohit Iran 17 402 1.4× 206 0.9× 104 0.8× 43 0.3× 101 1.0× 39 804
Paul A. LeBlanc United States 15 373 1.3× 551 2.3× 105 0.8× 96 0.8× 69 0.7× 37 989
Sylvie Canépa France 19 281 1.0× 173 0.7× 48 0.4× 92 0.7× 40 0.4× 29 752
Mrinmoy Das France 14 120 0.4× 320 1.4× 101 0.8× 64 0.5× 80 0.8× 27 623
Manuela Dürr Germany 9 376 1.3× 218 0.9× 237 1.9× 54 0.4× 42 0.4× 10 776
Sheena A. Linehan United Kingdom 11 256 0.9× 489 2.1× 73 0.6× 59 0.5× 114 1.1× 11 893
Adam J. Pelzek United States 13 389 1.3× 181 0.8× 92 0.7× 85 0.7× 35 0.3× 17 783

Countries citing papers authored by Daniel Drocourt

Since Specialization
Citations

This map shows the geographic impact of Daniel Drocourt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Drocourt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Drocourt more than expected).

Fields of papers citing papers by Daniel Drocourt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Drocourt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Drocourt. The network helps show where Daniel Drocourt may publish in the future.

Co-authorship network of co-authors of Daniel Drocourt

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Drocourt. A scholar is included among the top collaborators of Daniel Drocourt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Drocourt. Daniel Drocourt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Drocourt, Daniel, et al.. (2022). Antiviral Activities of HIV-1-Specific Human Broadly Neutralizing Antibodies Are Isotype-Dependent. Vaccines. 10(6). 903–903. 4 indexed citations
2.
Blanc, Landry, Martine Gilleron, Jacques Prandi, et al.. (2017). Mycobacterium tuberculosis inhibits human innate immune responses via the production of TLR2 antagonist glycolipids. Proceedings of the National Academy of Sciences. 114(42). 11205–11210. 72 indexed citations
3.
Decout, Alexiane, Sandro Silva‐Gomes, Daniel Drocourt, et al.. (2017). Rational design of adjuvants targeting the C-type lectin Mincle. Proceedings of the National Academy of Sciences. 114(10). 2675–2680. 89 indexed citations
4.
Ternant, David, Christophe Arnoult, Martine Pugnière, et al.. (2015). IgG1 Allotypes Influence the Pharmacokinetics of Therapeutic Monoclonal Antibodies through FcRn Binding. The Journal of Immunology. 196(2). 607–613. 51 indexed citations
5.
Rochereau, Nicolas, Daniel Drocourt, Éric Pérouzel, et al.. (2013). Dectin-1 Is Essential for Reverse Transcytosis of Glycosylated SIgA-Antigen Complexes by Intestinal M Cells. PLoS Biology. 11(9). e1001658–e1001658. 142 indexed citations
6.
Congy‐Jolivet, Nicolas, et al.. (2013). Production and characterization of chimeric anti-HLA monoclonal antibodies targeting public epitopes as tools for standardizations of the anti-HLA antibody detection. Journal of Immunological Methods. 390(1-2). 41–51. 14 indexed citations
7.
Drocourt, Daniel, et al.. (2013). Innate Immune Response of Alveolar Macrophage to House Dust Mite Allergen Is Mediated through TLR2/-4 Co-Activation. PLoS ONE. 8(10). e75983–e75983. 38 indexed citations
8.
Laffleur, Brice, Armelle Cuvillier, Marjolein van Egmond, et al.. (2012). Anti-CD20 IgA can protect mice against lymphoma development: evaluation of the direct impact of IgA and cytotoxic effector recruitment on CD20 target cells. Haematologica. 97(11). 1686–1694. 34 indexed citations
9.
Escoffre, Jean‐Michel, Jean-Paul Reynes, Daniel Drocourt, et al.. (2008). Long-lasting In vivo Gene Silencing by Electrotransfer of shRNA Expressing Plasmid. Technology in Cancer Research & Treatment. 7(2). 109–116. 12 indexed citations
10.
Vernejoul, Fabienne, Anny Souque, Hubert Lulka, et al.. (2006). Gene Therapy Based on Gemcitabine Chemosensitization Suppresses Pancreatic Tumor Growth. Molecular Therapy. 14(6). 758–767. 33 indexed citations
11.
Habib, Nagy, R Havlík, Long Jiao, et al.. (2004). Combination of optison with ultrasound and electroporation increases albumin and thrompoietin transgene expression whilst elongation factor promoter prolongs its duration. WestminsterResearch (University of Westminster). 3 indexed citations
12.
Cazaux, Christophe, et al.. (1998). Concomitant expression ofE. colicytosine deaminase and uracil phosphoribosyltransferase improves the cytotoxicity of 5-fluorocytosine. FEMS Microbiology Letters. 167(1). 41–49. 62 indexed citations
13.
Reynes, Jean-Paul, et al.. (1996). Escherichia coli thymidylate kinase: molecular cloning, nucleotide sequence, and genetic organization of the corresponding tmk locus. Journal of Bacteriology. 178(10). 2804–2812. 27 indexed citations
14.
Gautier, R., Daniel Drocourt, & Thierry Jaffredo. (1996). Generation of Small Fusion Genes Carrying Phleomycin Resistance andDrosophilaAlcohol Dehydrogenase Reporter Properties: Their Application in Retroviral Vectors. Experimental Cell Research. 224(2). 291–301. 12 indexed citations
16.
Drocourt, Daniel, et al.. (1988). Nucleotide sequence of the xylose isomerase gene fromStreptomyces violaceoniger. Nucleic Acids Research. 16(19). 9337–9337. 36 indexed citations
17.
Reynes, Jacques, et al.. (1988). Cloning, Expression in Escherichia coli and Nucleotide Sequence of a Tetracycline-resistance Gene from Streptomyces rimosus. Microbiology. 134(3). 585–598. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026